Navigation
Excelsio Media by Nelson Alarcón - alarcónnelson

Lilly to seek accelerated FDA approval for Alzheimer's drug this year

Lilly to seek accelerated FDA approval for Alzheimer's drug this year
Eli Lilly said on Thursday it will apply for U.S. health regulator's accelerated approval this year for its experimental Alzheimer's drug, weeks after Biogen Inc's (BIIB.O) controversial drug for the disease was approved.


Share

Excelsio Media

EXCELSIO Media, is an independent source of news and information.

Post A Comment:

0 comments:

Leave a comment. Thanks!